Annaida Technologies SA
MedTech, Women’s Health
_
Company profile
Annaida is a Swiss Healthtech company, who’s developed and patented a NMR technology, able to provide a fast, non-invasive and quantitative embryo screening, giving patients an improved overall IVF experience.
Chief Executive Officer
Marco Grisi
ARTIDIS AG
IVD, Oncology
_
Company profile
Artidis is a Swiss Healthtech company, who’s developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization, with a platform that allows physicians to optimize diagnostics.
Chief Executive Officer
Marija Plodinec
aspivix SA
MedTech, Women’s Health
_
Company profile
Aspivix is a Swiss medical device startup, devoted to women’s healthcare. The company has created a substitute for the tenaculum, in order to improve the Gynecological experience.
Chief Executive Officer
Mathieu Horras
BioReperia AB
IVD, Oncology
_
Company profile
BioReperia is a Swedish biotech company, based also in Switzerland, dedicated to provide services that accelerate anti-cancer drug discovery, assisting in selecting candidates efficiently and rapidly.
Chief Executive Officer
Anna Erkstam
Bottneuro AG
MedTech, Neurological Disorders
_
Company profile
Bottneuro is a spin-off of the University of Basel dedicated to the diagnosis and treatment of Alzheimer’s disease using digital biomarkers, brain imaging, and neuromodulation technology. In order to treat early- and moderate-stage AD patients, Bottneuro is developing a non-invasive, home-based treatment that targets glial cells using personalized electrical stimulation.
Chief Executive Officer
Bekim Osmani
Cellestia Biotech AG
BioTech, Oncology
_
Company profile
Cellestia Biotech is a research and development company that develops innovative first-in-class therapies by selectively inhibiting transcription factors in the cell nucleus in multiple disease areas. Currently, their lead compound CB-103 is in Phase 2 of clinical trials and successfully treating cancer patients who are resistant to multi-drug treatments.
Chief Executive Officer
Rajwinder Lehal
hemotune AG
MedTech, Sepsis_
Company profile
hemotune AG is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. It has designed a multi-target precision medicine blood purification treatment to restore immune balance in septic shock and improve patient outcomes.
Chief Executive Officer
Lukas Langenegger
Hi-D Imaging AG
MedTech, Cardiology
Company profile
Hi-D imaging is a Swiss medtech startup. HI-D is developing a new technology, supported by AI, that aims to revolutionize the medical imaging sector by reducing pre-operational/surgical planning complexity.
Chief Executive Officer
Utku Gülan
Resistell AG
IVD, Infectious Diseases
Company profile
Resistell is a Swiss medtech startup, working on a solution for SEPSIS. They’ve patented a technology able to deliver AST diagnostic results in hours instead of days, allowing clinicians to halt sepsis by providing the right treatment to the patient on time.
Chief Executive Officer
Danuta Cichocka
Scailyte AG
Data Analysis Platform, Oncology, Immunology
_
Company profile
Scailyte is a Swiss biotech company, the startup, with a data driven approach, is working on a solution that provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human’s hidden “single-cell” secrets.
Chief Executive Officer
Peter Nestorov
Sleepiz AG
MedTech, Sleep Disorders
_
Company profile
Sleepiz is a Swiss medtech startup, working on a device that operates in a non-contact fashion and measures movements originating from heart contractions and breathing patterns, as well as body motions with medical grade accuracy.
Chief Executive Officer
Soumya Sunder Dash
TOLREMO therapeutics AG
BioTech, Oncology_
Company profile
Tolremo is a Swiss biotechnology company. Based on cutting-edge science and guided by pioneering real-world medicine, the company created a broad cancer drug resistance platform that provides a unique entry point into a major clinical problem.
Chief Executive Officer
Stefanie Flückiger-Mangual
Exit
inQbator AG
Healthcare
Company profile
inQbator AG is a start-up accelerator that seeks the most promising innovative companies and help them grow through accelerator programs offering hands-on mentoring, specialized services and access to funding.
Founders
HEMEX, BLKB, Launchpad
What startups say about up
From the start of Resistell, HEMEX supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes HEMEX a unique partner in our journey to the market.
Dr. Danuta Cichocka
CEO, Resistell
With its impressive commitment to advance and fund healthcare innovations, its deep understanding of startup needs and its solid expertise in supporting regulatory and clinical operations, HEMEX is an exceptional partner that has been and continues to be instrumental in our journey.
Mathieu Horras
CEO, ASPIVIX